Summary

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.

The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.

The public comment period ends on May 7, after which the FDA may finalize the ban.

    • @Verat@sh.itjust.works
      link
      fedilink
      167 months ago

      By my understanding yes, pseudoephedrine was being used for meth so they put it behind the counter and the name brand “Sudafed” made a PE line that was this, phenylephrine, to stay over the counter.